Inside Precision Medicine December 9, 2025
Pharmacogenomics is heating up as excitement grows around artificial intelligence tools in genomics. Check out five startups gunning to meet the soaring demand.
Around 95% of the population has a gene variant that affects how we respond to at least one drug, often based on how well our bodies break down the molecule. If the drug is broken down by a patient’s body more slowly than normal, for example, the patient can experience more side effects than others.
For this reason, pharmacogenomics is a critical component of precision medicine, which aims to provide safe and effective medications tailored to a patient’s genome.
The global market for pharmacogenomics was worth $7.6 billion in 2024 and is expected to grow by 8.1%...
Today's Sponsors
Today's Sponsor